• Adrian Simpson, United States says, "If you are looking for a fair deal on medical supplies, IDM is something I would seriously recommend. Am hooked for life."
  • Craig, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "IDM makes online shopping a pleasure. Shopping is so simple that you just breeze through it."
  • Harry Mason, United States says, "I have to admit am a bit of a lazy bloke when it comes to ordering online .And IDM pampers me to the hit as it's so simple to order."
  • John Hanks, United States says, "I was a sceptic until my first order. After, I received my first package, I turned believer. Now, it’s been 3 years since I have been ordering from IDM."
  • Natalie Wallace, United States says, "I was apprehensive about how my doubts would be addressed but what the heck,I went ahead and placed my order. Customer service was patient and helped me out."
  • Mark Penning, United States says, "Happy I got my package just in time for my vacation. Needless to say, it made my holiday a wonderfully satisfying experience."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    You can find the latest happening of our pharmacy
    Follow us on Twitter

      Zydus Cadila launches anti-hypertension drugs in USA

      Posted AtSify.com

      Ahmedabad-based drug major Zydus Cadila today said that it has received approval from the US Food and Drug Administration (USFDA) to market two anti-hypertension drugs in the US market. These include Losartan Potassium tablets and Losartan Potassium plus Hydrochorothiazide tablets.

      The company has approval to market Losartan Potassium tablets in the denominations of 25 mg, 50mg, and 100mg, while it can sell the Lostartan plus Hydrochorothiazide tablets in denominations of 50/12.5mg and 100/25 mg. Zydus has already launched both the products in the US market post approval from the health regulator.

      As par NDC Health, sales of Losartan Potassium tablets in the US market is estimated at $1.3 billion and that of Losartan Potassium plus Hydrochlorothiazide tablets is estimated at $944 million in 2010.

      The Ahmedabad-based pharma major had launched Tamsulosin capsules (0.4mg) in the US in April.

      Following this approval, the group has now approvals for 56 products for the US market and has so far filed 113 abbreviated new drug application (ANDA) since the commencement of filing process in the fiscal 2003-04 fiscal.

      Zydus launched the anti-hypertensive drugs in the US market on the same day that it received the approval. It had done the same in case of Tasulosin capsules earlier this year. Apart from these two, the Group has had three more first day launches in the US market in 2008-09.

      Oct 12, 2010


      Share this Article!

    Back to top^